BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $305,601,506 | -27.9% | 6,085,255 | -9.3% | 0.03% | -27.8% |
| Q2 2023 | $423,954,258 | -46.6% | 6,708,137 | -62.0% | 0.04% | 0.0% |
| Q1 2023 | $793,814,538 | +101.9% | 17,644,244 | +96.6% | 0.04% | -7.7% |
| Q4 2022 | $393,174,816 | -33.4% | 8,974,545 | +0.2% | 0.04% | -37.1% |
| Q3 2022 | $590,238,000 | +36.3% | 8,957,926 | +4.5% | 0.06% | +44.2% |
| Q2 2022 | $433,178,000 | +27.1% | 8,576,079 | +60.8% | 0.04% | +59.3% |
| Q1 2022 | $340,696,000 | +35.4% | 5,333,381 | +127.1% | 0.03% | +42.1% |
| Q4 2021 | $251,542,000 | -23.8% | 2,348,452 | -26.9% | 0.02% | -26.9% |
| Q3 2021 | $330,222,000 | -11.7% | 3,211,964 | -24.4% | 0.03% | -10.3% |
| Q2 2021 | $373,841,000 | -10.0% | 4,250,131 | -0.5% | 0.03% | -17.1% |
| Q1 2021 | $415,524,000 | -11.6% | 4,273,616 | +2.0% | 0.04% | -16.7% |
| Q4 2020 | $469,951,000 | +32.4% | 4,190,375 | +9.4% | 0.04% | +16.7% |
| Q3 2020 | $354,935,000 | +21.0% | 3,828,849 | +1.8% | 0.04% | +12.5% |
| Q2 2020 | $293,322,000 | -1.8% | 3,760,541 | -26.4% | 0.03% | -22.0% |
| Q1 2020 | $298,700,000 | -49.5% | 5,107,719 | -30.8% | 0.04% | -36.9% |
| Q4 2019 | $591,147,000 | +9.4% | 7,379,190 | +0.3% | 0.06% | 0.0% |
| Q3 2019 | $540,439,000 | -19.8% | 7,355,923 | +2.9% | 0.06% | -17.7% |
| Q2 2019 | $674,010,000 | +21.3% | 7,145,238 | +3.0% | 0.08% | +17.9% |
| Q1 2019 | $555,491,000 | +56.3% | 6,939,294 | +5.3% | 0.07% | +36.7% |
| Q4 2018 | $355,405,000 | -30.8% | 6,592,556 | +0.1% | 0.05% | -15.5% |
| Q3 2018 | $513,881,000 | +23.1% | 6,583,159 | +0.1% | 0.06% | +20.8% |
| Q2 2018 | $417,419,000 | -30.3% | 6,575,600 | +0.7% | 0.05% | -32.4% |
| Q1 2018 | $598,911,000 | +23.5% | 6,531,199 | +1.6% | 0.07% | +24.6% |
| Q4 2017 | $484,958,000 | +18.6% | 6,430,959 | +9.6% | 0.06% | +16.3% |
| Q3 2017 | $408,748,000 | +52.2% | 5,866,903 | +10.7% | 0.05% | +48.5% |
| Q2 2017 | $268,581,000 | +40.4% | 5,300,589 | +10.8% | 0.03% | +37.5% |
| Q1 2017 | $191,302,000 | +75.9% | 4,783,754 | +23.4% | 0.02% | +60.0% |
| Q4 2016 | $108,782,000 | -6.8% | 3,878,140 | -1.3% | 0.02% | -6.2% |
| Q3 2016 | $116,705,000 | +41.1% | 3,929,462 | -3.8% | 0.02% | +45.5% |
| Q2 2016 | $82,733,000 | +12.6% | 4,085,600 | +0.4% | 0.01% | +10.0% |
| Q1 2016 | $73,463,000 | -20.7% | 4,069,985 | +15.7% | 0.01% | -16.7% |
| Q4 2015 | $92,624,000 | +6.7% | 3,516,473 | -13.5% | 0.01% | 0.0% |
| Q3 2015 | $86,786,000 | -19.4% | 4,066,818 | +0.0% | 0.01% | -14.3% |
| Q2 2015 | $107,727,000 | – | 4,066,710 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
| DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
| Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
| Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
| CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
| Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
| Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
| Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
| Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
| EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |